Press Release: Source Biomagnetics Diagnostics Corporation

Biomagnetics Diagnostics Engages Platinum Productions to Promote a Media Campaign with Nationwide Coverage Tuesday March 20, 9:01 am ET

ORANGEVALE, Calif.--(BUSINESS WIRE)--March 20, 2007--Biomagnetics Diagnostics Corp. (OTC: BMGP - News) announced today that it has engaged Platinum Productions to produce a media campaign regarding their proprietary diagnostic technology.

After a strenuous review, Biomagnetics has been approved to participate in a technology Health Forum to air once nationally on Fox News and 25 times on Regional News Networks in up to 15 DMA (Direct Marketing Association) markets.

The DMA is the leading global trade association of business and nonprofit organizations using and supporting direct marketing tools and techniques. Founded in 1917, DMA today has more than 3,600 members from the US and 46 other nations, including the majority of companies listed on the Fortune 100.

Clayton Hardman, President and CEO of Biomagnetics Diagnostics Corp., stated, "We are very excited to be working with Platinum Productions to help raise awareness of our technologies and how our products can potentially revolutionize the diagnostics arena. Being approved for this opportunity only solidifies and strengthens our growing footprint in our vastly expanding industry."

About Biomagnetics Diagnostics Corporation

Biomagnetics Diagnostics Corporation, through its wholly owned subsidiary, Biospectrum Technologies, Inc., a company that has designed and patented revolutionary diagnostic equipment and immunoassays, will identify market inadequacies and fill those needs with new technologies, and highly specific and sensitive assays that are qualitative (yes/no) and quantitative (viral load/degree of infection), easily performed and cost effective.

For more information please visit: www.biomagneticsbmgp.com

Forward-Looking Statement

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company's SEC filings. These risks and uncertainties could cause the company's actual results to differ materially from those indicated in the forward-looking statements.

Contact: Paul Hardman, (916) 987-7078
Source: BioMag Corp.